The role of stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) in locally advanced and borderline resectable pancreatic cancer
- PMID: 39817234
- PMCID: PMC11729814
- DOI: 10.21037/atm-24-170
The role of stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) in locally advanced and borderline resectable pancreatic cancer
Keywords: Pancreatic cancer; magnetic resonance-guided adaptive radiotherapy (MRgART); stereotactic body radiation therapy (SBRT); stereotactic magnetic resonance-guided adaptive radiotherapy (SMART).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-24-170/coif). The authors have no conflicts of interest to declare.
Comment on
-
Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study.Radiother Oncol. 2024 Feb;191:110064. doi: 10.1016/j.radonc.2023.110064. Epub 2023 Dec 20. Radiother Oncol. 2024. PMID: 38135187 Clinical Trial.
References
-
- National Cancer Audit Collaborating Centre, Royal College of Surgeons of England. National Pancreatic Cancer Audit State of the Nation Report 2024. London: Healthcare Quality Improvement Partnership; 2024.
-
- Pancreatic cancer incidence statistics [Internet]. Cancer Research UK; 2024 [cited 2024 Dec 2]. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s...
-
- Radiotherapy dose fractionation fourth edition [Internet]. Royal College of Radiologists; 2024 [cited 2024 Dec 2]. Available online: https://www.rcr.ac.uk/our-services/all-our-publications/clinical-oncolog...
Publication types
LinkOut - more resources
Full Text Sources